 | • レポートコード：B-GIR09D2471 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、腫瘍薬の世界市場について調べ、まとめました。種類別セグメントは、代謝拮抗薬、アルカロイド薬、ホルモン、標的薬、プラチナ系製剤、その他等、用途別セグメントは、血液癌、乳癌、胃腸癌、前立腺癌、呼吸器/肺癌、その他等に区分しました。腫瘍薬の世界市場概観、メーカー動向、メーカー別腫瘍薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・腫瘍薬の市場概観 ・腫瘍薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腫瘍薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・腫瘍薬の世界市場規模 ・腫瘍薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・腫瘍薬のアメリカ市場規模推移 ・腫瘍薬のカナダ市場規模推移 ・腫瘍薬のメキシコ市場規模推移 ・腫瘍薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・腫瘍薬のドイツ市場規模推移 ・腫瘍薬のイギリス市場規模推移 ・腫瘍薬のロシア市場規模推移 ・腫瘍薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・腫瘍薬の日本市場規模推移 ・腫瘍薬の中国市場規模推移 ・腫瘍薬の韓国市場規模推移 ・腫瘍薬のインド市場規模推移 ・腫瘍薬の東南アジア市場規模推移 ・腫瘍薬の南米市場分析（ブラジル、アルゼンチン等） ・腫瘍薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・腫瘍薬の種類別分析/販売量、売上、市場シェア（代謝拮抗薬、アルカロイド薬、ホルモン、標的薬、プラチナ系製剤、その他） ・腫瘍薬の用途別分析/市場規模（血液癌、乳癌、胃腸癌、前立腺癌、呼吸器/肺癌、その他） ・腫瘍薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・腫瘍薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Scope of the Report:
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.
The worldwide market for Oncology Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Oncology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other
Market Segment by Applications, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
There are 15 Chapters to deeply display the global Oncology Drugs market.
Chapter 1, to describe Oncology Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oncology Drugs, with sales, revenue, and price of Oncology Drugs, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncology Drugs, for each region, from 2014 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
Chapter 12, Oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Oncology Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
1.1 Oncology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Antimetabolite
1.2.2 Alkaloid drugs
1.2.3 Hormone
1.2.4 Targeted drug
1.2.5 Platinum-based drugs
1.2.6 Other
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Nigeria Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Oncology Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 HENGRUI
2.2.1 Business Overview
2.2.2 Oncology Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 HENGRUI Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Oncology Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 QILU
2.4.1 Business Overview
2.4.2 Oncology Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 QILU Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Oncology Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 HANSOH
2.6.1 Business Overview
2.6.2 Oncology Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 HANSOH Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 LUYE
2.7.1 Business Overview
2.7.2 Oncology Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LUYE Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Oncology Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 GuiZhou YiBai
2.9.1 Business Overview
2.9.2 Oncology Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GuiZhou YiBai Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Lunan
2.10.1 Business Overview
2.10.2 Oncology Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Lunan Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Eli Lilly and Company
2.11.1 Business Overview
2.11.2 Oncology Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eli Lilly and Company Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Oncology Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Oncology Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Oncology Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncology Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Oncology Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Oncology Drugs Market Analysis by Regions
4.1 Global Oncology Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Oncology Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Oncology Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Oncology Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Oncology Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Oncology Drugs Sales and Growth Rate (2014-2019)
4.5 South America Oncology Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Oncology Drugs Sales and Growth Rate (2014-2019)
5 North America Oncology Drugs by Countries
5.1 North America Oncology Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Oncology Drugs Sales and Market Share by Countries (2014-2019)
5.1.2 North America Oncology Drugs Revenue and Market Share by Countries (2014-2019)
5.2 United States Oncology Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Oncology Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Oncology Drugs Sales and Growth Rate (2014-2019)
6 Europe Oncology Drugs by Countries
6.1 Europe Oncology Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Oncology Drugs Sales and Market Share by Countries (2014-2019)
6.1.2 Europe Oncology Drugs Revenue and Market Share by Countries (2014-2019)
6.2 Germany Oncology Drugs Sales and Growth Rate (2014-2019)
6.3 UK Oncology Drugs Sales and Growth Rate (2014-2019)
6.4 France Oncology Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Oncology Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Oncology Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Oncology Drugs by Countries
7.1 Asia-Pacific Oncology Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oncology Drugs Sales and Market Share by Countries (2014-2019)
7.1.2 Asia-Pacific Oncology Drugs Revenue and Market Share by Countries (2014-2019)
7.2 China Oncology Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Oncology Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Oncology Drugs Sales and Growth Rate (2014-2019)
7.5 India Oncology Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Oncology Drugs Sales and Growth Rate (2014-2019)
8 South America Oncology Drugs by Countries
8.1 South America Oncology Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Oncology Drugs Sales and Market Share by Countries (2014-2019)
8.1.2 South America Oncology Drugs Revenue and Market Share by Countries (2014-2019)
8.2 Brazil Oncology Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Oncology Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Oncology Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Oncology Drugs by Countries
9.1 Middle East and Africa Oncology Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oncology Drugs Sales and Market Share by Countries (2014-2019)
9.1.2 Middle East and Africa Oncology Drugs Revenue and Market Share by Countries (2014-2019)
9.2 Saudi Arabia Oncology Drugs Sales and Growth Rate (2014-2019)
9.3 UAE Oncology Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Oncology Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Oncology Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Oncology Drugs Sales and Growth Rate (2014-2019)
10 Global Oncology Drugs Market Segment by Type
10.1 Global Oncology Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Oncology Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Oncology Drugs Revenue and Market Share by Type (2014-2019)
10.2 Antimetabolite Sales Growth and Price
10.2.1 Global Antimetabolite Sales Growth (2014-2019)
10.2.2 Global Antimetabolite Price (2014-2019)
10.3 Alkaloid drugs Sales Growth and Price
10.3.1 Global Alkaloid drugs Sales Growth (2014-2019)
10.3.2 Global Alkaloid drugs Price (2014-2019)
10.4 Hormone Sales Growth and Price
10.4.1 Global Hormone Sales Growth (2014-2019)
10.4.2 Global Hormone Price (2014-2019)
10.5 Targeted drug Sales Growth and Price
10.5.1 Global Targeted drug Sales Growth (2014-2019)
10.5.2 Global Targeted drug Price (2014-2019)
10.6 Platinum-based drugs Sales Growth and Price
10.6.1 Global Platinum-based drugs Sales Growth (2014-2019)
10.6.2 Global Platinum-based drugs Price (2014-2019)
10.7 Other Sales Growth and Price
10.7.1 Global Other Sales Growth (2014-2019)
10.7.2 Global Other Price (2014-2019)
11 Global Oncology Drugs Market Segment by Application
11.1 Global Oncology Drugs Sales Market Share by Application (2014-2019)
11.2 Blood Cancer Sales Growth (2014-2019)
11.3 Breast Cancer Sales Growth (2014-2019)
11.4 Gastrointestinal Cancer Sales Growth (2014-2019)
11.5 Prostate Cancer Sales Growth (2014-2019)
11.6 Respiratory/Lung Cancer Sales Growth (2014-2019)
11.7 Other Sales Growth (2014-2019)
12 Oncology Drugs Market Forecast (2019-2024)
12.1 Global Oncology Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Oncology Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Oncology Drugs Market Forecast (2019-2024)
12.2.2 Europe Oncology Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Oncology Drugs Market Forecast (2019-2024)
12.2.4 South America Oncology Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Oncology Drugs Market Forecast (2019-2024)
12.3 Oncology Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Oncology Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Oncology Drugs Market Share Forecast by Type (2019-2024)
12.4 Oncology Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Oncology Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Oncology Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Oncology Drugs Picture
Table Product Specifications of Oncology Drugs
Figure Global Sales Market Share of Oncology Drugs by Types in 2018
Table Oncology Drugs Types for Major Manufacturers
Figure Antimetabolite Picture
Figure Alkaloid drugs Picture
Figure Hormone Picture
Figure Targeted drug Picture
Figure Platinum-based drugs Picture
Figure Other Picture
Figure Oncology Drugs Sales Market Share by Applications in 2018
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Picture
Figure United States Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Oncology Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Oncology Drugs Type and Applications
Table Roche Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table HENGRUI Basic Information, Manufacturing Base and Competitors
Table HENGRUI Oncology Drugs Type and Applications
Table HENGRUI Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Oncology Drugs Type and Applications
Table AstraZeneca Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table QILU Basic Information, Manufacturing Base and Competitors
Table QILU Oncology Drugs Type and Applications
Table QILU Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Oncology Drugs Type and Applications
Table Sanofi Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table HANSOH Basic Information, Manufacturing Base and Competitors
Table HANSOH Oncology Drugs Type and Applications
Table HANSOH Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table LUYE Basic Information, Manufacturing Base and Competitors
Table LUYE Oncology Drugs Type and Applications
Table LUYE Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Oncology Drugs Type and Applications
Table Novartis Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GuiZhou YiBai Basic Information, Manufacturing Base and Competitors
Table GuiZhou YiBai Oncology Drugs Type and Applications
Table GuiZhou YiBai Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Lunan Basic Information, Manufacturing Base and Competitors
Table Lunan Oncology Drugs Type and Applications
Table Lunan Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Oncology Drugs Type and Applications
Table Eli Lilly and Company Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Oncology Drugs Sales by Manufacturer (2017-2018)
Figure Global Oncology Drugs Sales Market Share by Manufacturer in 2017
Figure Global Oncology Drugs Sales Market Share by Manufacturer in 2018
Table Global Oncology Drugs Revenue by Manufacturer (2017-2018)
Figure Global Oncology Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Oncology Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Oncology Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Oncology Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Global Oncology Drugs Revenue and Growth Rate (2014-2019)
Table Global Oncology Drugs Sales by Regions (2014-2019)
Table Global Oncology Drugs Sales Market Share by Regions (2014-2019)
Table Global Oncology Drugs Revenue by Regions (2014-2019)
Figure Global Oncology Drugs Revenue Market Share by Regions in 2014
Figure Global Oncology Drugs Revenue Market Share by Regions in 2018
Figure North America Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Europe Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Oncology Drugs Sales and Growth Rate (2014-2019)
Figure South America Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Oncology Drugs Sales and Growth Rate (2014-2019)
Figure North America Oncology Drugs Revenue and Growth Rate (2014-2019)
Table North America Oncology Drugs Sales by Countries (2014-2019)
Table North America Oncology Drugs Sales Market Share by Countries (2014-2019)
Figure North America Oncology Drugs Sales Market Share by Countries in 2014
Figure North America Oncology Drugs Sales Market Share by Countries in 2018
Table North America Oncology Drugs Revenue by Countries (2014-2019)
Table North America Oncology Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Oncology Drugs Revenue Market Share by Countries in 2014
Figure North America Oncology Drugs Revenue Market Share by Countries in 2018
Figure United States Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Canada Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Europe Oncology Drugs Revenue and Growth Rate (2014-2019)
Table Europe Oncology Drugs Sales by Countries (2014-2019)
Table Europe Oncology Drugs Sales Market Share by Countries (2014-2019)
Table Europe Oncology Drugs Revenue by Countries (2014-2019)
Figure Europe Oncology Drugs Revenue Market Share by Countries in 2017
Figure Europe Oncology Drugs Revenue Market Share by Countries in 2018
Figure Germany Oncology Drugs Sales and Growth Rate (2014-2019)
Figure UK Oncology Drugs Sales and Growth Rate (2014-2019)
Figure France Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Russia Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Italy Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Oncology Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Oncology Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Oncology Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Oncology Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Oncology Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Oncology Drugs Revenue Market Share by Countries 2018
Figure China Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Japan Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Korea Oncology Drugs Sales and Growth Rate (2014-2019)
Figure India Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Oncology Drugs Sales and Growth Rate (2014-2019)
Figure South America Oncology Drugs Revenue and Growth Rate (2014-2019)
Table South America Oncology Drugs Sales by Countries (2014-2019)
Table South America Oncology Drugs Sales Market Share by Countries (2014-2019)
Figure South America Oncology Drugs Sales Market Share by Countries in 2018
Table South America Oncology Drugs Revenue by Countries (2014-2019)
Table South America Oncology Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Oncology Drugs Revenue Market Share by Countries in 2018
Figure Brazil Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Oncology Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Oncology Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Oncology Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Oncology Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Oncology Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Oncology Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oncology Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Oncology Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Oncology Drugs Sales and Growth Rate (2014-2019)
Figure UAE Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Oncology Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Oncology Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Oncology Drugs Sales and Growth Rate (2014-2019)
Table Global Oncology Drugs Sales by Type (2014-2019)
Table Global Oncology Drugs Sales Share by Type (2014-2019)
Table Global Oncology Drugs Revenue by Type (2014-2019)
Table Global Oncology Drugs Revenue Share by Type (2014-2019)
Figure Global Antimetabolite Sales Growth (2014-2019)
Figure Global Antimetabolite Price (2014-2019)
Figure Global Alkaloid drugs Sales Growth (2014-2019)
Figure Global Alkaloid drugs Price (2014-2019)
Figure Global Hormone Sales Growth (2014-2019)
Figure Global Hormone Price (2014-2019)
Figure Global Targeted drug Sales Growth (2014-2019)
Figure Global Targeted drug Price (2014-2019)
Figure Global Platinum-based drugs Sales Growth (2014-2019)
Figure Global Platinum-based drugs Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Oncology Drugs Sales by Application (2014-2019)
Table Global Oncology Drugs Sales Share by Application (2014-2019)
Figure Global Breast Cancer Sales Growth (2014-2019)
Figure Global Gastrointestinal Cancer Sales Growth (2014-2019)
Figure Global Prostate Cancer Sales Growth (2014-2019)
Figure Global Respiratory/Lung Cancer Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Oncology Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Oncology Drugs Sales Forecast by Regions (2019-2024)
Table Global Oncology Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Oncology Drugs Market Forecast (2019-2024)
Figure Europe Sales Oncology Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Oncology Drugs Market Forecast (2019-2024)
Figure South America Sales Oncology Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Oncology Drugs Market Forecast (2019-2024)
Table Global Oncology Drugs Sales Forecast by Type (2019-2024)
Table Global Oncology Drugs Market Share Forecast by Type (2019-2024)
Table Global Oncology Drugs Sales Forecast by Application (2019-2024)
Table Global Oncology Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…- 世界の胆管がん治療薬市場予測（～2024年） Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unkno…
- 世界の新がん診断市場予測（～2024年） Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation. Scope of the Report: The global Emerging Cancer Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between …
- 世界の男性乳癌治療市場予測（～2024年） Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation. Scope of the Report: The glo…
- 世界のパーソナライズ癌医学市場予測（～2024年） Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors c…